← Back to headlines
Tango Therapeutics Stock Soars on Pancreatic Cancer Trial Results
Tango Therapeutics (TNGX) shares surged following positive results from its pancreatic cancer trial.
9 Jun, 13:29 — 9 Jun, 13:29
Sources
Showing 1 of 1 sources
Related Stories
US-Iran Military Escalation Sparks Retaliatory Strikes and Market Volatility
25m ago
BP Appoints Ian Tyler as New Chairman Following Leadership Transition
30m ago
Everus Construction and California Resources Finalize Major Corporate Acquisitions
49m ago
Nvidia Nears $14 Billion Acquisition of AI Startup Hugging Face
1h ago